News

The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.
DNLI announced that the FDA has accepted for review its biologics license application (BLA) for lead-pipeline candidate ...
August Egg Company issued a voluntary recall on June 6 following reports of numerous salmonella infections across multiple states.
Though the listeria recall was upgraded, information remains limited. Here's what we know about the recall, which is active only in NC.
RAHWAY, N.J.-- (BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted ...
FDA approved Lyme kit - ID FISH Technology, Inc. Using both IgM and IgG tests allows for full diagnostic coverage of a disease. IgM antibodies are produced first and suggest a current or recent ...
FDA Will Now Require Labeling of ADHD Medication to Indicate Weight Loss Risk Jul 2, 2025 Updated Jul 2, 2025 child scale weight ...
The FDA is requiring a Limitation of Use section be added to the prescribing information of all extended-release stimulants. This section will include a statement about the higher plasma exposures and ...